Amanote Research
Register
Sign In
MicroRNA Regulation of Oncolytic Adenovirus 6 for Selective Treatment of Castration-Resistant Prostate Cancer
Molecular Cancer Therapeutics
- United States
doi 10.1158/1535-7163.mct-12-0157
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
August 22, 2012
Authors
Z. Zhang
X. Zhang
K. Newman
X. Liu
Publisher
American Association for Cancer Research (AACR)
Related search
Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
The Treatment Patterns of Castration Resistant Prostate Cancer in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Aggressive Variants of Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Effect of Dutasteride on Castration‑resistant Prostate Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Molecular Mechanisms of Castration-Resistant Prostate Cancer Progression
Future Oncology
Medicine
Cancer Research
Oncology
Late-Phase miRNA-controlled Oncolytic Adenovirus for Selective Killing of Cancer Cells
Oncotarget
Oncology
Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Visceral Disease in Castration-Resistant Prostate Cancer
European Urology
Urology
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
Yearbook of Paediatric Endocrinology
